Skip to main content

Elanco Animal Health Inc

corporate_fare Company Profile

Elanco Animal Health Inc

ELAN·NYSE·Life Sciences·CIK 0001739104

Elanco Animal Health Incorporated is a global leader in animal health, focused on innovating and delivering products and services to prevent and treat disease in farm animals and pets. The company partners with farmers, pet owners, veterinarians, and society to improve animal health. Elanco's diverse product portfolio is sold in more than 90 countries. Its products serve various animal species, primarily dogs and cats (referred to as pet health) and cattle, poultry, swine, and sheep (referred to as farm animal). The company aims to address critical health needs and increase access to health products and services for animals. For customers, Elanco provides science-based, scalable, and sustainable solutions to unlock economic value for producers and supports the professional wellness of veterinarians. The company also focuses on recruiting, retaining, and empowering its workforce. Furthermore, Elanco is committed to improving human health through animals, delivering reliable products, and safeguarding the food system, ensuring consumer and pet owner health and safety, and protecting the accessibility and availability of affordable animal protein.

Elanco Animal Health Inc (NYSE:ELAN) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 21 items for ELAN at importance 7 or higher on its 1–10 market-impact scale.

Recent high-impact activity:

  • Elanco Outlines Path to Consistent Growth, Higher Profitability, and Strong Cash Flow at JPM Conference

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$4.71B
Net Income
-$232M
Diluted EPS
-$0.47
Op. Cash Flow
$560M
Free Cash Flow
$284M
Gross Profit
$2.59B
Cash & Equivalents
$545M
Total Debt
$3.76B
Debt / Equity
0.57×
Net Margin
-4.9%
Shares Outstanding
496.98M sh
Source: 10-K · filed 2026-02-24 · accession 0001739104-26-000012
$25.22 -2.04% today
52-week range · as of 2026-11-06 $19.4 – $27.98
Market cap
$12.87B
Volume
5.8M (1.1× avg)
3-mo avg 5.4M
Live data · 2026-11-22 03:54 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed ELAN - Filings & News (Page 2)

ELAN
Jan 12, 2026, 8:00 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $23.55
Real-time Price: $25.22 info
Change: +$1.67 (+7%) info
Market Cap: $12.866B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets